Catherine Moukheibir - 16 Jun 2026 Form 4 Insider Report for IRONWOOD PHARMACEUTICALS INC (IRWD)

Reporting relationship: Director
Issuer ticker: IRWD
Reported as of: 16 Jun 2026
Net transaction value: $0
SEC form: 4
Accepted by SEC: 17 Jun 2026, 16:36:28 UTC
Prior SEC filing: 07 Jul 2025
Next SEC filing: 18 Jun 2026
Source filing: View source filing
Reporting owner signature: /s/ Amir Vitale, Attorney-in-Fact

Key filing fact

Catherine Moukheibir filed Form 4 for IRONWOOD PHARMACEUTICALS INC (IRWD) on 17 Jun 2026.

Key facts

This page summarizes Catherine Moukheibir's Form 4 filing for IRONWOOD PHARMACEUTICALS INC (IRWD).
1 reported transaction and 0 derivative rows are listed below.
Accepted by SEC: 17 Jun 2026, 16:36.

Change

Previous filing in this sequence was filed on 07 Jul 2025.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001772130 Primary reporting owner

Moukheibir Catherine

Relationship: Director
Address: C/O IRONWOOD PHARMACEUTICALS, INC., 100 SUMMER STREET, SUITE 2300, BOSTON
Signature: /s/ Amir Vitale, Attorney-in-Fact
Signature date: 17 Jun 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

IRWD transaction

Class A Common Stock

Award

Transaction value
Shares: +63,481
Change %: +54%
Price: $0.000000^*
Shares after: 181,425
Date: 16 Jun 2026
Ownership: Direct
Footnotes: F1

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

The restricted stock, granted pursuant to the Second Amended and Restated Non-employee Director Compensation Policy, effective January 1, 2024, vests in full on the date immediately preceding the date of the annual meeting of stockholders for the next calendar year.

SEC remarks

Exhibit 24 - Power of Attorney